uCloudlink Group UCL Q1 2026 Earnings NarrowerThanExpected Loss Fails to Propel Stock Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses RSG Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick FITBI Q1 2026 Earnings Strong EPS Beat Highlights Resilient Core Operations C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage Integra Resources ITRG Q1 2026 Earnings EPS Falls Short of Expectations Amid Exploration Focus